APA
Anagnostopoulos T., Pertesi M., Konstantopoulou I., Armaou S., Kamakari S., Nasioulas G., Athanasiou A., Dobrovic A., Young M., Goldgar D., Fountzilas G. & Yannoukakos D. (20090424). G1738R is a BRCA1 founder mutation in Greek breast/ovarian cancer patients: evaluation of its pathogenicity and inferences on its genealogical history. : Breast cancer research and treatment.
Chicago
Anagnostopoulos Theodore, Pertesi Maroulio, Konstantopoulou Irene, Armaou Sofia, Kamakari Smaragda, Nasioulas George, Athanasiou Athanassios, Dobrovic Alex, Young Mary-Anne, Goldgar David, Fountzilas George and Yannoukakos Drakoulis. 20090424. G1738R is a BRCA1 founder mutation in Greek breast/ovarian cancer patients: evaluation of its pathogenicity and inferences on its genealogical history. : Breast cancer research and treatment.
Harvard
Anagnostopoulos T., Pertesi M., Konstantopoulou I., Armaou S., Kamakari S., Nasioulas G., Athanasiou A., Dobrovic A., Young M., Goldgar D., Fountzilas G. and Yannoukakos D. (20090424). G1738R is a BRCA1 founder mutation in Greek breast/ovarian cancer patients: evaluation of its pathogenicity and inferences on its genealogical history. : Breast cancer research and treatment.
MLA
Anagnostopoulos Theodore, Pertesi Maroulio, Konstantopoulou Irene, Armaou Sofia, Kamakari Smaragda, Nasioulas George, Athanasiou Athanassios, Dobrovic Alex, Young Mary-Anne, Goldgar David, Fountzilas George and Yannoukakos Drakoulis. G1738R is a BRCA1 founder mutation in Greek breast/ovarian cancer patients: evaluation of its pathogenicity and inferences on its genealogical history. : Breast cancer research and treatment. 20090424.